Answers are grounded in this paper and cite their sources.
Sir, Gamma-glutamyl transferase (GGT) is an enzyme found in the hepatobiliary system, pancreas, and kidneys, playing a crucial role in glutathione metabolism and detoxification and is a commonly used biomarker of liver function, alcohol consumption, and oxidative stress. GGT can be elevated in liver disease, cholestasis, and alcohol-related and drug-induced liver injury (DILI). Other conditions include medications (e.g., rifampicin, phenytoin, statins), obesity, and inflammation. It is nonspecific, and an isolated GGT elevation may be due to microsomal enzyme induction, which may not always be of concern. A detailed evaluation is imperative to identify benign causes and avoid unwanted interruption of antitubercular therapy (ATT). A 27-year-old male, diagnosed with tubercular lymphadenopathy (based on clinical evaluation, imaging, and molecular studies), on first-line ATT for 5 months, was detected with persistent elevation of GGT on routine follow-up. He had improved symptomatically, with regression in the size of the lymph nodes, but showed GGT elevation, while other liver function tests remained normal. Examination revealed bilateral cervical lymphadenopathy, with no other significant systemic examination findings. He was extensively evaluated, with normal blood counts, liver and kidney functions, viral serology, and normal hepatobiliary imaging [Table 1]. Since the patient was asymptomatic with no features suggestive of hepatocellular dysfunction or cholestasis, the GGT elevation was probably due to the enzyme induction by ATT drugs, particularly rifampicin. Follow-up investigations after ATT showed a resolving trend in GGT. Table 1 - Summary of Investigations. Hemoglobin 13.3g/dL Total Leucocyte Count 6,600/mm3(N48L40M10) Platelets 2,51,000/mm3 Bilirubin Total 0.46mg/dL AST/ALT 35/36 IU/L ALP 116 IU/L GGT 182 IU/L Urea/ Creatinine 23/0.74 mg/dL TSH 1.189 µU/mL (0.5-4.7) HBsAg/ Anti HCV/ Anti HbC serology Non Reactive HBV DNA/ HCV RNA PCR Not Detected ANA/ASMA/Anti LKM/ Ig Profile Normal Ultrasonography Neck Bilateral cervical lymphadenopathy with multiple necrotic lymph nodes Lymph node aspirate Xpert MTB/Rif Mycobacterium tuberculosis bacilli not detected Ultrasonography Abdomen Normal Scan MRCP (Magnetic Resonance Cholangiopancreatography) Normal Study AST-Aspartate aminotransferase, ALT-Alanine transaminase, ALP-Alkaline Phosphatase, GGT-Gamma Glutamyl transferase, TSH- Thyroid stimulating hormone, HBsAg-Hepatitis B Surface Antigen, HCV- Hepatitis C Virus, HbC- Hepatitis Core Antigen, HBV DNA- Hepatitis B Virus Deoxyribonucleic Acid, HCV RNA- Hepatitis C Virus Ribonucleic Acid, PCR- Polymerase chain reaction, ANA-Anti nuclear Antibody, ASMA- Anti- Smooth Muscle Antibody, LKM-Liver Kidney Microsome, Ig- Immunoglobulin GGT elevations are mostly associated with hepatobiliary disease. It is often elevated in tuberculosis (TB), with an isolated rise [without accompanying elevation of alanine transaminase (ALT), aspartate transaminase, or bilirubin] can have several causes. Rifampicin, which is a core drug in ATT, activates pregnane X receptor, leading to hepatic enzyme induction and an increase in GGT and alkaline phosphatase (ALP) levels without causing actual liver injury. It stimulates the bile salt export pump and multidrug resistance–associated protein 2, increasing bile flow and mildly increasing GGT levels without hepatobiliary dysfunction. Rifampicin, along with the other ATT drugs such as isoniazid and pyrazinamide, induces cytochrome P450 enzymes, leading to asymptomatic GGT elevations.[1,2] As per the 2019 EASL(European Association for the Study of the Liver) guidelines, DILI is defined by at least one of the following: (1) ALT elevation ≥5 times the upper limit of normal (ULN); (2) ALP elevation ≥2 times ULN; and (3) ALT elevation ≥3 times ULN accompanied by bilirubin >2 times ULN. The risk increases with the duration of treatment and time of identification.[3,4] TB can cause oxidative stress and nutrient depletion, contributing to GGT upregulation. Coexisting conditions such as obesity, alcohol intake, and hepatotropic infections may also be contributing factors. There may be an initial increase in GGT and subsequent adjustments as the body adapts. Transaminase levels can indicate liver inflammation. It is important to recognize these patterns, keeping in mind the fact that these vary based on patient characteristics, the dynamics of infection, compliance, and potential drug interactions. Benign GGT elevation is a common, nonpathologic finding linked to enzyme induction or other conditions rather than hepatocellular injury. Isolated GGT elevation is usually not concerning and does not require discontinuation of therapy. However, persistent or extreme elevated levels should prompt further evaluation, including detailed imaging, etiological screening, and metabolic assessment, to differentiate benign enzymatic changes from potential liver injury.[5,6]
No takes yet. Share an insight, caveat, or question.
Mohanan et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: